政府科技投入对医药企业技术创新的门槛效应分析

发布时间：2018-03-10 19:33

本文选题：政府科技投入　切入点：企业研发投入　出处：《中国新药杂志》2016年08期 　论文类型：期刊论文

【摘要】：目的:研究政府科技投入对医药企业研发投入的门槛效应,并测算出政府科技投入最优规模,为提高医药企业技术创新提供政策建议。方法:运用2000-2013年26个省市医药制造业的面板数据建立门槛回归模型。结果:政府科技投入对医药企业研发投入具有门槛效应,随着政府科技投入强度的增加,医药企业研发投入强度呈现出先增大后减小的趋势,政府科技投入的最优规模区间为(12.08%,17.27%)。结论:应从整体上继续加大对医药企业技术创新的投入,并将政府科技投入控制在合理范围内,既充分发挥资助效率又防止资源浪费,最大程度激励医药企业技术创新。
[Abstract]:Objective: to study the threshold effect of government science and technology investment on R & D investment of pharmaceutical enterprises, and calculate the optimal scale of government science and technology investment. Methods: using panel data from 26 provinces and cities from 2000 to 2013 to establish a threshold regression model. Results: government investment in science and technology has a threshold effect on R & D investment of pharmaceutical enterprises. With the increase of the scientific and technological investment intensity of the government, the R & D investment intensity of the pharmaceutical enterprises shows a tendency of increasing first and then decreasing. The optimal scale of the scientific and technological investment of the government is 12.08 and 17.270.Conclusion: we should continue to increase the investment in the technological innovation of the pharmaceutical enterprises as a whole. The government investment in science and technology should be controlled within a reasonable range to give full play to the efficiency of financial aid and to prevent the waste of resources, and to stimulate the technological innovation of pharmaceutical enterprises to the greatest extent.
【作者单位】：中国药科大学国际医药商学院;
【基金】：中央高校基本科研业务费项目:政府科技投入对我国医药制造业技术创新影响的异质性及对策研究(2015PYW03)
【分类号】：F273.1;F426.72

【相似文献】